Redfin (RDFN) shares soared 80% pre-bell Monday after the company agreed to be acquired by Rocket Companies (RKT) in a deal worth $1.75 billion.
Checkpoint Therapeutics (CKPT) shares surged 67% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $4.10 per share in cash plus a contingent value right.
Trevi Therapeutics (TRVI) shares advanced 32% after the company said its phase 2a trial of Haduvio for the treatment of patients with refractory chronic cough met its primary endpoint.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.